Purchase Order 19BE1022P0001
Award Date 12/21/21
Potential Completion Date 1/21/22
Potential Value $124K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Ireland
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a firm fixed-price purchase order valued at $11,896.50 by the Bureau of Administration for medical supplies. The contract, with an ultimate completion date of March 6, 2026, was awarded on February 5, 2026, with no set-aside designation. Performance will occur in Lake Mary, Florida. Abbott Rapid DX specializes in point-of-care diagnostic testing devices and medical supplies, with a particular focus on...
- This is a firm fixed-price purchase order contract awarded by the Bureau of Administration, a civilian agency, to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc. The contract, valued at $12,060.60, is for the delivery of medical supplies. The period of performance runs through February 1, 2024. This award does not have a set-aside designation. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products, including rapid antigen tests, in vitro...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $3,600.00 for COVID-19 test kits on December 8, 2025, with an ultimate completion date of December 17, 2025. The contract utilizes a fixed-price structure with economic price adjustment and was issued without a set-aside designation. Performance will take place in Lake Mary, Florida. This delivery order is funded through the Defense Logistics Agency's Medical Supply Chain, a...
- This is a $16,875.00 firm-fixed price purchase order contract awarded to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, by the Bureau of Administration, a civilian federal agency. The contract is for the delivery of medical supplies, with a completion date of January 12, 2024. It does not have a set-aside designation. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products, including rapid antigen tests, to various government agencies,...
- This is a federal contract award from the Bureau of Administration, a civilian agency, to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The contract is for the delivery of $15,461.30 in medical supplies, specifically COVID-19 diagnostic products including rapid antigen tests, in vitro diagnostics, and molecular diagnostic testing platforms. The contract has a firm fixed price and does not utilize a set-aside designation. Abbott Rapid DX North America LLC, which...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $6,000 fixed-price delivery order on December 16, 2025, for COVID-19 virus test kits with an ultimate completion date of December 26, 2025. The delivery order, issued under contract 4570300223, was funded by the Defense Logistics Agency Medical Supply Chain and will be performed in Lake Mary, Florida. This award utilizes no small business set-aside designation and reflects Abbott's established role as a...
- This federal contract award, worth $34,990.26, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The contract is for the delivery of BinaxNOW COVID-19 Antigen Cards to support the government's response to the Coronavirus (COVID-19) pandemic. This is a firm fixed-price delivery order with an ultimate completion date of October 9, 2020. The contract is not set aside for any specific business category....
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $2,400 delivery order (Contract No. 4569814561) for COVID-19 test kits on October 24, 2025, with an ultimate completion date of November 4, 2025. The contract utilizes a fixed-price structure with economic price adjustment provisions and is performed in Lockhart, Florida. This delivery order is funded by the Defense Logistics Agency's Medical Supply Chain, which is a defense-oriented federal agency...
- The U.S. government awarded a $1,200.00 fixed-price delivery order contract to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, for the supply of COVID-19 test kits. The contract, which has an ultimate completion date of May 22, 2025, was awarded by the Defense Logistics Agency (DLA) Medical Supply Chain. This contract is not set aside for a specific business category. Abbott Rapid DX North America LLC is a key supplier of medical diagnostic equipment and testing...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a fixed-price delivery order contract worth $1,776.00 to Abbott Rapid DX North America LLC, doing business as Alere, a subsidiary of Abbott Laboratories. The contract is for the delivery of COVID-19 test kits by February 22, 2024. This contract is not set aside and is part of a larger medical equipment and supplies Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle that Abbott Laboratories holds with the Defense...
The Department of State Bureau of Administration awarded a firm fixed-price purchase order contract to Abbott Rapid DX International LIMITED Ardx Division, a foreign-owned for-profit manufacturer, for the delivery of COVID-19 testing kits. The contract has a potential value of $123,600.00 and a completion date of January 21, 2022. The contract does not have a set-aside designation. Abbott Rapid DX International LIMITED has also received numerous subcontracts from Chemonics International, Inc. to provide a variety of rapid diagnostic test kits, including tests for Hepatitis B, Hepatitis C, syphilis, tuberculosis, and HIV, to support HIV treatment and care activities through a USAID-funded project in several countries.
Generated 3/23/24, 8:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $123.6k | 12/21/21 |